The highest risk of death from prostate cancer is associated with increased waist circumference, increased blood pressure, hypertension, type 2 diabetes and obesity; thus, therapies that can reduce blood glucose levels have the potential to improve patient outcomes. The therapeutic benefits of low-carbohydrate and fasting-mimicking diets in patients with prostate cancer have been investigated in two recent studies.
Your institute does not have access to this article
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Lavalette, C. et al. Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget 9, 34485–34494 (2018).
Häggström, C. et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer 118, 6199–6206 (2012).
Geng, J.-H. et al. Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00494-w (2022).
Mohamedali, H. Z., Breunis, H., Timilshina, N. & Alibhai, S. M. H. Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer. Can. Urol. Assoc. J. 5, 28–32 (2011).
Chi, J.-T. et al. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00525-6 (2022).
Seyfried, T. N., Arismendi-Morillo, G., Mukherjee, P. & Chinopoulos, C. On the origin of ATP synthesis in cancer. iScience 23, 101761 (2020).
Seyfried, T. N., Yu, G., Maroon, J. C. & D’Agostino, D. P. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr. Metab. 14, 19 (2017).
Fay-Watt, V. et al. The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00528-3 (2022).
Vayalil, P. K. & Landar, A. Mitochondrial oncobioenergetic index: a potential biomarker to predict progression from indolent to aggressive prostate cancer. Oncotarget 6, 43065–43080 (2015).
Lopaschuk, G. D., Hess, D. A. & Verma, S. Ketones regulate endothelial homeostasis. Cell Metab. 34, 513–515 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Seyfried, T.N. The effects of diet on prostate cancer outcomes. Nat Rev Urol 19, 389–390 (2022). https://doi.org/10.1038/s41585-022-00612-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00612-2